Clinical Trials Browser

Carcinoma, Transitional Cell × Trastuzumab × Clear all

NCT05318339 2022-04-08

A Study of Trastuzumab and Pyrotinib in HER2 Positive Locally Advanced or Metastatic Urothelial Carcinoma

Phase 2 Unknown

Carcinoma, Transitional Cell

NCT01828736 2017-02-06

CVH-CT02

Phase 2 Completed

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell